Shailja Shah

Dr. Shailja Shah

University of California - san diego
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2021 in Gastroenterology
Verified
Journal Article
Closed access
SSShailja Shah
Shailja Shah
MPM. Blanca Piazuelo
M. Blanca Piazuelo
EKErnst J. Kuipers
Ernst J. Kuipers
DLDan Li
Dan Li

1 December 2019 in Journal of Global Oncology
Verified
Journal Article
Open access
SSShailja Shah
Shailja Shah
Violet KayambaViolet Kayamba
Violet Kayamba
RPRichard M. Peek
Richard M. Peek
DHDouglas Heimburger
Douglas Heimburger
The rising prevalence of noncommunicable diseases globally, with a strikingly disproportionate increase in prevalence and related mortality in low- and middle-income countries (LMICs), is a major threat to sustainable development. The epidemiologic trend of cancers in LMICs is of particular concern. Despite a lower incidence of cancer in LMICs compared with high-income countries, total cancer-related mortality is significantly higher in LMICs, especially in people younger than 65 years of age. The enormous economic impact of premature mortality and lost productive life years highlights the critical importance of galvanizing cancer prevention and management to achieve sustainable development. The rising burden of cancer in LMICs stresses an already weak health care and economic infrastructure and poses unique challenges. Although the WHO acknowledges that the effective management of cancer relies on early detection, accurate diagnosis, and access to appropriate multimodal therapy, the placement of priority on early detection cannot be assumed to be effective in LMICs, where limited downstream resources may be overwhelmed by the inevitable increases in number of diagnoses. This review discusses several factors and considerations that may compromise the success of cancer control programs in LMICs, particularly if the focus is only on early detection through screening and surveillance. It is intended to guide optimal implementation of cancer control programs by accentuating challenges common in LMICs and by emphasizing the importance of cancer prevention where relevant so that communities and stakeholders can work together to devise optimal means of combatting the growing burden of cancer.

29 January 2021 in Gastroenterology
Verified
Journal Article
Open access
SSShailja Shah
Shailja Shah
PIPrasad G. Iyer
Prasad G. Iyer
SMSteven F. Moss
Steven F. Moss
The purpose of this CPU Expert Review is to provide clinicians with guidance on the management of Helicobacter pylori after an initial attempt at eradication therapy fails, including best practice advice on specific regimen selection, and consideration of patient and systems factors that contribute to treatment efficacy. This Expert Review is not a formal systematic review, but is based upon a review of the literature to provide practical advice. No formal rating of the strength or quality of the evidence was carried out. Accordingly, a combination of available evidence and consensus-based expert opinion were used to develop these best practice advice statements.

24 December 2024 in Gastroenterology
Verified
Journal Article
Closed access
SSShailja Shah
Shailja Shah
AWAndrew Y. Wang
Andrew Y. Wang
MWMichael B. Wallace
Michael B. Wallace
JHJoo Ha Hwang
Joo Ha Hwang

1 January 2020 in Therapeutic Advances in Gastroenterology
Verified
Journal Article
Open access
PDF file
SRSheila D. Rustgi
Sheila D. Rustgi
MKMaia Kayal
Maia Kayal
SSShailja Shah
Shailja Shah
Sex-based differences in inflammatory bowel disease (IBD) pathogenesis, disease course, and response to therapy have been increasingly recognized, however, not fully understood. Experimental and translational models have been leveraged to investigate hypothesized mechanisms for these observed differences, including the potential modifying role of sex hormones and sex-dependent (epi)genetic and gut microbiome changes. The primary objective of this review is to comprehensively describe sex-based differences in IBD including epidemiology, pathogenesis, phenotypic differences, therapeutic response, and outcomes.

6 December 2019 in Gastroenterology
Verified
Journal Article
Open access
AGAndrew J. Gawron
Andrew J. Gawron
SSShailja Shah
Shailja Shah
OAOsama Altayar
Osama Altayar
PDPerica Davitkov
Perica Davitkov
DMDouglas Morgan
Douglas Morgan
RMReem A. Mustafa
Reem A. Mustafa